Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. SRDX
stocks logo

SRDX

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
AI Stock Picker
AI Stock Picker

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
30.14M
-9.29%
-0.180
+38.46%
30.01M
+0.3%
-0.130
+225%
30.45M
+8.41%
-0.025
-80.77%
Estimates Revision
The market is revising No Change the revenue expectations for Surmodics, Inc. (SRDX) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 32.74%.
Revenue Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
EPS Estimates for FY2025
No Change
down Image
0.00%
In Past 3 Month
Stock Price
Go Up
up Image
+32.74%
In Past 3 Month
Wall Street analysts forecast SRDX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SRDX is USD with a low forecast of 32.00 USD and a high forecast of 32.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
1 Analyst Rating
Wall Street analysts forecast SRDX stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for SRDX is USD with a low forecast of 32.00 USD and a high forecast of 32.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
0 Buy
1 Hold
0 Sell
Hold
Current: 42.990
sliders
Low
32.00
Averages
High
32.00
Current: 42.990
sliders
Low
32.00
Averages
High
32.00
Barrington
Michael Petusky
Market Perform -> Underperform
downgrade
2025-11-14
Reason
Barrington
Michael Petusky
Price Target
2025-11-14
downgrade
Market Perform -> Underperform
Reason
Barrington analyst Michael Petusky downgraded Surmodics to Underperform from Market Perform given that shares are now trading within 3.3% of the GTCR merger offer. The firm thinks investors should consider exiting the position and sees little to no possibility of a higher bid emerging at this point, the analyst tells investors.
Lake Street
Brooks O'Neil
Hold
to
Strong Buy
Upgrades
$43
2025-03-07
Reason
Lake Street
Brooks O'Neil
Price Target
$43
2025-03-07
Upgrades
Hold
to
Strong Buy
Reason
Needham
Mike Matson
Hold
Reiterates
n/a
2025-01-30
Reason
Needham
Mike Matson
Price Target
n/a
2025-01-30
Reiterates
Hold
Reason
See All Ratings

Valuation Metrics

The current forward P/E ratio for Surmodics Inc (SRDX.O) is -116.16, compared to its 5-year average forward P/E of -36.45. For a more detailed relative valuation and DCF analysis to assess Surmodics Inc 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PE
-36.45
Current PE
-116.16
Overvalued PE
46.92
Undervalued PE
-119.83

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
18.10
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
65.59
Undervalued EV/EBITDA
-29.38

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
4.48
Current PS
0.00
Overvalued PS
5.86
Undervalued PS
3.10
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Intellectia AI SwingMax
Intellectia AI SwingMax

SRDX News & Events

Events Timeline

(ET)
2025-11-17
06:13:21
FTC Will Not Appeal Surmodics' Acquisition
select
2025-11-10 (ET)
2025-11-10
20:07:56
Surmodics announces District Court's rejection of preliminary injunction request
select
2025-11-10
17:31:05
GTCR's Acquisition of Surmodics Can Move Forward, According to Reuters
select
link
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
4.5
11-12NASDAQ.COM
Stocks Close Mostly Up Amid Optimism for Government Reopening

  • US Stock Market Performance: The S&P 500 and Dow Jones closed higher, driven by optimism over a potential end to the government shutdown, while the Nasdaq 100 faced pressure from declines in AI and semiconductor stocks.

  • Labor Market Concerns: A report from ADP indicated a decline in private sector jobs, and the NFIB small business optimism index fell to a six-month low, suggesting a weakening labor market.

  • Corporate Earnings Update: Q3 earnings season showed strong results, with 82% of S&P 500 companies exceeding forecasts, leading to a 14.6% increase in earnings, significantly above expectations.

  • Interest Rates and Economic Outlook: The markets are anticipating a 67% chance of a rate cut at the upcoming FOMC meeting, while European bond yields fell amid mixed economic indicators, including a decline in German economic growth expectations.

[object Object]
Preview
4.5
11-12NASDAQ.COM
Dow and S&P Gain Ground While Nasdaq Experiences Selling Pressure

  • US Stock Market Performance: The S&P 500 and Dow Jones indexes are up, while the Nasdaq is down, influenced by declines in AI and semiconductor stocks, particularly CoreWeave and Nvidia. Trading volume is low due to the Veterans Day holiday.

  • Labor Market Indicators: A report from ADP indicates a weakening labor market, with private employers shedding an average of 11,250 jobs weekly. Additionally, the NFIB small business optimism index fell to a six-month low.

  • Government Shutdown Developments: The Senate passed a temporary resolution to fund the government, with expectations for quick approval in the House, which could lead to the end of the government shutdown and resumption of federal payments.

  • Corporate Earnings and Market Reactions: Q3 earnings reports show 82% of S&P 500 companies exceeded forecasts, with earnings rising 14.6%. However, several tech stocks, including Micron and AMD, are experiencing declines, while others like Surmodics and RealReal are seeing significant gains.

[object Object]
Preview
4.5
11-12Benzinga
Dow Rises Over 300 Points; Energy Vault Holdings Stock Soars

  • Market Performance: U.S. stocks showed mixed results, with the Dow Jones gaining 0.64% while the NASDAQ and S&P 500 fell by 0.79% and 0.23%, respectively.

  • Sector Highlights: Energy shares rose by 1.2%, while information technology stocks experienced a decline of 0.9%.

  • Notable Stock Movements: RealReal Inc. saw a significant rise after positive earnings, while enGene Holdings Inc. surged 72% following promising study results. Conversely, Vor Biopharma Inc. and Salarius Pharmaceuticals Inc. both dropped 50% due to public offering announcements.

  • International Markets: European shares increased, with the eurozone's STOXX 600 up 1.05%, while Asian markets closed mixed, with Japan's Nikkei 225 slightly down and India's BSE Sensex up 0.40%.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Surmodics Inc (SRDX) stock price today?

The current price of SRDX is 42.99 USD — it has increased 0.35 % in the last trading day.

arrow icon

What is Surmodics Inc (SRDX)'s business?

Surmodics, Inc. is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic immunoassay tests and microarrays. It also develops and commercializes highly differentiated vascular intervention medical devices that are designed to address unmet clinical needs and engineered to the demanding requirements. Its segments include Medical Device and IVD. Medical Device segment manufactures and licenses performance coatings, including surface modification coating technologies to improve access, deliverability and predictable deployment of medical devices and drug-delivery coating technologies to provide site-specific drug-delivery from the surface of a medical device, with end markets that include neurovascular, peripheral and coronary. IVD segment manufactures chemical and biological components used in in vitro diagnostic immunoassay and molecular tests within the diagnostic and biomedical research markets.

arrow icon

What is the price predicton of SRDX Stock?

Wall Street analysts forecast SRDX stock price to fall over the next 12 months. According to Wall Street analysts, the average 1-year price target for SRDX is  USD with a low forecast of 32.00 USD and a high forecast of 32.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Surmodics Inc (SRDX)'s revenue for the last quarter?

Surmodics Inc revenue for the last quarter amounts to 29.57M USD, decreased -2.55 % YoY.

arrow icon

What is Surmodics Inc (SRDX)'s earnings per share (EPS) for the last quarter?

Surmodics Inc. EPS for the last quarter amounts to -0.37 USD, decreased -30.19 % YoY.

arrow icon

What changes have occurred in the market's expectations for Surmodics Inc (SRDX)'s fundamentals?

The market is revising No Change the revenue expectations for Surmodics, Inc. (SRDX) for FY2025, with the revenue forecasts being adjusted by 0% over the past three months. During the same period, the stock price has changed by 32.74%.
arrow icon

How many employees does Surmodics Inc (SRDX). have?

Surmodics Inc (SRDX) has 389 emplpoyees as of December 05 2025.

arrow icon

What is Surmodics Inc (SRDX) market cap?

Today SRDX has the market capitalization of 598.49M USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free